Advertisement

Topics

Search Results for "Cancer Diagnostics"

15:18 EST 4th December 2016 | BioPortfolio

Matching Channels

Matching News

Cancer diagnostics market is witnessing high growth

Cancer diagnostics market is witnessing high growth due to increasing prevalence and incidences of several types of cancers. The post Cancer diagnostics market is witnessing high growth appeared firs...

Personal Genome Diagnostics to participate in US Cancer Moonshot effort to jump start liquid biopsy database

Personal Genome Diagnostics (PGDx), a leading provider of advanced cancer genome testing products and services, has announced its participation in the Blood Profiling Atlas pilot of the Cancer Moonsho...

Biotheranostics & Syapse Collaborate to Integrate Genomics-Based Molecular Diagnostics for Cancer into the Syapse Precision Medicine Platform

Breast Cancer Index & CancerTYPE ID Tests Provide Patient-Specific Information to Aid in Treatment Decisions with the Goal of Improving Outcomes SAN DIEGO & PALO ALTO, Calif.–(BUSINESS W...

Biotheranostics & Syapse Collaborate to Integrate Genomics-Based Molecular Diagnostics for Cancer into the Syapse Precision Medicine Platform

Thursday, September 22nd 2016 at 5:18pm UTC Breast Cancer Index & CancerTYPE ID Tests Provide Patient-Specific Information to Aid in Treatment Decisions with the Goal of Improving Outcomes SAN DIE...

Backed by UPMC, Cancer Diagnostics Startup Cernostics Lands $5M

Cernostics, a Pittsburgh, PA-based cancer diagnostics startup has raised $5 million in funding led by UPMC Enterprises, UPMC’s venture capital arm with participation from Novitas Capital. The co...

IBM, Quest Diagnostics introduce new service to offer cancer treatments for patients

IBM Watson Health and Quest Diagnostics have introduces new service, which will enable physicians to provide precision cancer treatments for patients across the US.

Cost-effective diagnostics for cancer? Only with VolitionRx!

Aberdeen, we say goodbye to you! We’re leaving Scotland this week and are heading down to Belgium. Besides being the place where most of the European Union action happens, Belgium also has a st...

Interpace Diagnostics introduces new pancreatic cancer testing product

Interpace Diagnostics Group has introduced a new version of its AccuCEA product dubbed Insights for pancreatic cancer testing.

Matching PubMed Articles

Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.

The importance of RAS mutation in carcinogenesis is established, and knowledge of an individual cancer's mutation status is important for optimal treatment.

Single-cell proteomics: potential implications for cancer diagnostics.

Single-cell proteomics in cancer is evolving and promises to provide more accurate diagnoses based on detailed molecular features of cells within tumors. This review focuses on technologies that allow...

Modern molecular biomarkers of head and neck cancer. Part I. Epigenetic diagnostics and prognostics: Systematic review.

Nearly half of the head and neck cancer cases are diagnosed in late stages. Traditional screening modalities have many disadvantages. The aim of the present article was to review the scientific litera...

MicroRNAs: A Puzzling Tool in Cancer Diagnostics and Therapy.

MicroRNAs (miRNAs) constitute a dominating class of small RNAs that regulate diverse cellular functions. Due the pivotal role of miRNAs in biological processes, a deregulated miRNA expression is likel...

Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics-Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer.

Companion diagnostics (CDx) have become a major tool in molecular pathology and assist in therapy decisions in an increasing number of various cancers. Particularly, the developments in lung cancer ha...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement